NRIX — Nurix Therapeutics Inc. price, chart and key statistics

Price data

Price

$24.42

YTD price return

+28.73%

YTD total return

+28.73%

Market cap

2.5B2020-09 1.4B2026-10 2.5B+86.7% over the window

Enterprise value

2.1B

Shares outstanding

103.8M2019-11 3.6M2026-05 103.8M+2786.6% over the window

52W low

$9.71

52W high

$28.23

From 52W high

-13.50%

From 52W low

+151.49%

52W range

79%

Volume

Rel volume

1.95×

30D volume

1.9M

30D $ vol

45.5M

Fundamentals

Sales (ttm)

36.8M2019-11 31.1M2026-05 36.8M+18.2% over the window

Sales/share

$0.352019-11 $8.652026-05 $0.35-95.9% over the window

EPS (ttm)

-$3.412020-08 -$2.182026-05 -$3.41+56.8% over the window

FCF (ttm)

-304.5M2019-11 -1.1M2026-05 -304.5M+28902.6% over the window

FCF/share

-$2.932019-11 -$0.292026-05 -$2.93+904.7% over the window

Book value/share

$3.882019-11 -$16.052026-05 $3.88-124.2% over the window

Net margin

-928.44%2019-11 -69.7%2026-05 -928.4%+1231.3% over the window

ROE

-84.78%2020-08 -12.0%2026-05 -84.8%+607.8% over the window

ROA

-63.74%2019-11 -49.3%2026-05 -63.7%+29.4% over the window

Current ratio

6.342019-11 2.442026-05 6.34+159.9% over the window

Growth (CAGR, ttm) · 10Y

Sales

-58.43%2025-05-31 → 2026-05-3188.4M → 36.8M (-58.4% total)-15.50%2023-05-31 → 2026-05-3160.9M → 36.8M (-39.7% total)+9.96%2021-05-31 → 2026-05-3122.9M → 36.8M (+60.7% total)n/a

Shares

+35.78%2025-05-31 → 2026-05-3176.4M → 103.8M (+35.8% total)+29.12%2023-05-31 → 2026-05-3148.2M → 103.8M (+115.3% total)+18.50%2021-05-31 → 2026-05-3144.4M → 103.8M (+133.6% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-69.38%2025-05-31 → 2026-05-31$1.16 → $0.35 (-69.4% total)-34.55%2023-05-31 → 2026-05-31$1.26 → $0.35 (-72.0% total)-7.21%2021-05-31 → 2026-05-31$0.51 → $0.35 (-31.2% total)n/a

Book value/share

-33.76%2025-05-31 → 2026-05-31$5.85 → $3.88 (-33.7% total)-10.39%2023-05-31 → 2026-05-31$5.39 → $3.88 (-28.1% total)-15.42%2021-05-31 → 2026-05-31$8.96 → $3.88 (-56.7% total)n/a

Price

+143.62%2025-10-16 → 2026-10-16$10.03 → $24.42 (+143.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+56.17%2023-10-16 → 2026-10-16$6.41 → $24.42 (+281.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-3.26%2021-10-15 → 2026-10-16$28.83 → $24.42 (-15.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+143.62%2025-10-16 → 2026-10-16$10.03 → $24.42 (+143.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+56.17%2023-10-16 → 2026-10-16$6.41 → $24.42 (+281.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-3.26%2021-10-15 → 2026-10-16$28.83 → $24.42 (-15.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-7.2×2020-09 -36.812026-10 -7.42-79.8% over the window

Fwd P/E

-21.2×

P/S (ttm)Market cap ÷ TTM revenue.

68.9×2020-09 104.402026-10 68.88-34.0% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

6.3×2020-09 4.412026-10 6.29+42.6% over the window

EV/Sales (ttm)

58.4×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-12.02%2020-11 -0.4%2026-05 -12.1%+3239.8% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-05-31) ÷ shares_at(2025-05-31) = 1 − 103.8M ÷ 76.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-35.78%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-35.78%) + dividends paid over that year ($0) ÷ market_cap_at(2025-05-31) ($810.4M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-35.78%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-18M) ÷ today's market cap ($2.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-0.71%2020-11 -17.1%2026-05 -0.7%-95.8% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-18M + TTM dividends $0) ÷ today's market cap ($2.5B). Same caveat as the cash buyback yield.

-0.71%2020-11 -17.1%2026-05 -0.7%-95.8% over the window

Vs own 10Y history

P/S

88th

P/B

97th